PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-2.53%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.17B
AUM Growth
+$2.17B
(-8.4%)
Cap. Flow
-$68.3M
Cap. Flow
% of AUM
-3.15%
Top 10 Holdings %
Top 10 Hldgs %
36.12%
Holding
88
New
9
Increased
22
Reduced
22
Closed
13
Top Buys
| 1 |
Becton Dickinson
BDX
|
$37.4M |
| 2 |
DexCom
DXCM
|
$33.5M |
| 3 |
Legend Biotech
LEGN
|
$22.8M |
| 4 |
Acadia Healthcare
ACHC
|
$22.5M |
| 5 |
Ascendis Pharma
ASND
|
$21.7M |
Top Sells
| 1 |
Cigna
CI
|
$46.8M |
| 2 |
Biogen
BIIB
|
$43.1M |
| 3 |
AstraZeneca
AZN
|
$39.1M |
| 4 |
Axsome Therapeutics
AXSM
|
$30M |
| 5 |
Agilent Technologies
A
|
$27.5M |
Sector Composition
| 1 | Healthcare | 95.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $119M | 5.26% |
1,091,840
| – | – |
|
2
Eli Lilly
LLY
$657B
| $103M | 4.53% |
298,643
| – | – |
|
3
Penumbra
PEN
$10.6B
| $100M | 4.43% |
360,030
| – | – |
|
4
Cytokinetics
CYTK
$4.23B
| $84.4M | 3.73% |
2,399,545
| – | – |
|
5
Humana
HUM
$36.5B
| $80.6M | 3.56% |
166,066
| – | – |
|
6
Centene
CNC
$14.3B
| $70.3M | 3.11% |
1,112,480
| – | – |
|
7
iRhythm Technologies
IRTC
$5.46B
| $60.2M | 2.66% |
485,468
-8,253
| -2% | -$1.02M |
|
8
UnitedHealth
UNH
$281B
| $54.9M | 2.42% |
116,067
| – | – |
|
9
Edwards Lifesciences
EW
$47.8B
| $53.7M | 2.37% |
648,633
+118,603
| +22% | +$9.81M |
|
|
10
DexCom
DXCM
$29.5B
| $49.2M | 2.17% |
423,816
+288,351
| +213% | +$33.5M |
|
11
Merck
MRK
$210B
| $49.1M | 2.17% |
461,118
+93,484
| +25% | +$9.95M |
|
12
Cardinal Health
CAH
$35.5B
| $48.3M | 2.13% |
639,783
| – | – |
|
13
AbbVie
ABBV
$372B
| $46M | 2.03% |
288,903
-40,441
| -12% | -$6.45M |
|
14
Intuitive Surgical
ISRG
$170B
| $45.7M | 2.02% |
178,863
+64,413
| +56% | +$16.5M |
|
|
SGEN
15
DELISTED
Seagen Inc. Common Stock
SGEN
| $44.7M | 1.98% |
220,883
+28,499
| +15% | +$5.77M |
|
16
Danaher
DHR
$147B
| $44.3M | 1.96% |
175,690
| – | – |
|
17
uniQure
QURE
$896M
| $42.5M | 1.88% |
2,110,070
-192,244
| -8% | -$3.87M |
|
18
Syndax Pharmaceuticals
SNDX
$1.41B
| $41.1M | 1.82% |
1,946,652
+132,018
| +7% | +$2.79M |
|
19
IQVIA
IQV
$32.4B
| $40M | 1.77% |
201,037
-28,044
| -12% | -$5.58M |
|
20
HCA Healthcare
HCA
$94.5B
| $39.2M | 1.73% |
148,500
+56,555
| +62% | +$14.9M |
|
21
argenx
ARGX
$43.6B
| $39M | 1.72% |
104,732
| – | – |
|
22
Molina Healthcare
MOH
$9.8B
| $38.5M | 1.7% |
143,779
| – | – |
|
23
McKesson
MCK
$85.4B
| $37.7M | 1.66% |
105,811
| – | – |
|
24
Prothena Corp
PRTA
$441M
| $37.5M | 1.66% |
774,546
-100,918
| -12% | -$4.89M |
|
|
25
Axsome Therapeutics
AXSM
$6.05B
| $37.4M | 1.65% |
606,081
-486,750
| -45% | -$30M |
|